Dr J Vijay Venkatraman , MD and CEO, Oviya MedSafe and Karunakaran Shanmugam , QA Associate, Oviya MedSafe, advocate implementing pharmacovigilance in a prudent manner to augment the growth of the Indian pharma industry Dr J Vijay Venkatraman ... Express Pharma, 2 weeks ago
MADURAI: A person living in Tamil Nadu gets familiarised with it right from school. From text books to public notifications of state departments, the emblem of Tamil Nadu is ubiquitous. The symbol features a 'gopuram' (temple tower) - characteristic ...Times of India, 3 weeks ago
Global $8.23 Billion Pharmacovigilance (In-House & Outsourcing) Market Analysis and Forecasts, 2022 - Research and Markets
/PRNewswire/ -- Research and Markets has announced the addition of the "Global Pharmacovigilance Market Analysis and Forecast, 2015-2022" report to their offering. The pharmacovigilance market is expected to reach a market size of $8.23 billion by ...TickerTech.com, 1 month ago Global Pharmacovigilance Market Analysis and Forecast, 2015-2022: Key Drivers, Challenges and Opportunities for the $8.23 Billion Pharmacovigilance Market Yahoo! Finance, 1 month ago Global Pharmacovigilance Market to Swell Over $8.23 Billion By 2022 - Increasing Incidents of ADRs Acting as Growth Driver - Research and Markets 4 Traders, 1 month ago
on your WebpageAdd Widget >Get your members hooked!